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The potential effects of combinations of dilute whole diesel exhaust (DE) and ozone (O3), each a common
component of ambient airborne pollutant mixtures, on lung function were examined. Healthy young human
volunteers were exposed for 2 hr to pollutants while exercising (~50 L/min) intermittently on two consecutive days.
Day 1 exposures were either to filtered air, DE (300 μg/m3), O3 (0.300 ppm), or the combination of both pollutants.
On Day 2 all exposures were to O3 (0.300 ppm), and Day 3 served as a followup observation day. Lung function
was assessed by spirometry just prior to, immediately after, and up to 4 hr post-exposure on each exposure day.
Functional pulmonary responses to the pollutants were also characterized based on stratification by glutathione
S-transferase mu 1 (GSTM1) genotype. On Day 1, exposure to air or DE did not change FEV1 or FVC in the subject
population (n = 15). The co-exposure to O3 and DE decreased FEV1 (17.6%) to a greater extent than O3 alone (9.9%).
To test for synergistic exposure effects, i.e., in a greater than additive fashion, FEV1 changes post individual O3 and
DE exposures were summed together and compared to the combined DE and O3 exposure; the p value was 0.057.
On Day 2, subjects who received DE exposure on Day 1 had a larger FEV1 decrement (14.7%) immediately after the
O3 exposure than the individuals’ matched response following a Day 1 air exposure (10.9%). GSTM1 genotype did
not affect the magnitude of lung function changes in a significant fashion. These data suggest that altered respiratory
responses to the combination of O3 and DE exposure can be observed showing a greater than additive manner. In
addition, O3-induced lung function decrements are greater with a prior exposure to DE compared to a prior exposure
to filtered air. Based on the joint occurrence of these pollutants in the ambient environment, the potential exists
for interactions in more than an additive fashion affecting lung physiological processes.
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Numerous epidemiological studies have demonstrated
an association between short-term exposure to ambient
airborne particulate matter (PM) and adverse cardiopul-
monary effects including premature mortality, increased
hospitalizations for lung problems including infections,
exacerbation of asthma symptoms, chronic bronchitis,
and hospitalization for clinical cardiac events including
arrhythmias, myocardial infarctions, and congestive heart* Correspondence: madden.michael@epa.gov
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unless otherwise stated.failure [1,2]. The health effects are more strongly associated
with PM that is smaller than 2.5 μm, i.e. PM2.5, which typ-
ically is derived from human based activities such as ve-
hicular emissions. PM2.5 is a complex mixture of organic
and inorganic compounds absorbed onto carbonaceous
material with the composition varying across space and
time. In this complex mixture of ambient air substances,
the ubiquitous pollutants ozone (O3) and diesel exhaust
(DE) can be can be major and important components. DE
can have “hotspots” such as bus terminals and major
streets [3]. Levels of DE PM2.5 reached transient concen-
trations of several hundred μg/m3 during drive-by studies
[4]. O3 levels have generally been decreasing in the US,
but can reach over 0.1 ppm on a regular basis.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in terms of lung biological effects. With dozens of con-
trolled human exposures, biological responses have been
well documented particularly for induction of decrements
of lung function and inflammation typically expressed
as decreased FEV1 and FVC [5] and lung neutrophilia
[6,7]. in a concentration-response manner (typically
0.08-0.4 ppm). Repeated exposure studies with healthy
young adults inhaling 0.4 ppm O3 for 2 hrs have shown
a decrement in lung function after the first exposure
and an even greater decrement after a second day expos-
ure, but then attenuated lung function decrements for the
next 3 exposure days [8,9]. Some reports have linked cer-
tain genetic polymorphisms to possible sensitivities to O3
exposure. For example, individuals exercising on a bike
outdoors for 2 hr with ambient O3 levels > 0.08 ppm had
greater lung function decrements as a group when they
possessed a glutathione-S-transferase mu 1 (GSTM1)
null genotype coupled with wild type NQO1 compared
to other combinations of those 2 gene polymorphisms
[10]. BMI has also been proportionally associated with
O3-induced lung function decrements [11].
Lung function decrements are typically not induced by
exposure to DE or PM alone in controlled study designs
[12]. Controlled ambient PM exposure studies in humans
have been used to examine biological responses as surro-
gates for understanding the health effects and mechanisms
involved in the responses. A dose-dependent increase in
total number of cells, neutrophils, and monocytes was ob-
served in the lung lavage fluid in contrast to lung function.
For instance, healthy human volunteers exposed to
300 μg/m3 DE for one hour with intermittent exercise
resulted in marked systemic and pulmonary inflamma-
tory responses [13,14].
There is interest in examining whether ambient pollu-
tant gases can modify the biological effect induced by PM
[15]. A handful of controlled exposure studies have shown
an interactive effect of PM and O3 exposure especially with
blood and cardiac endpoints. For instance blood pressure
increases have been noted with co-exposure of healthy
and also asthmatic subjects to O3 and concentrated ambi-
ent particles (CAPS) [16]. Increased vasoconstriction in
humans occurred upon exposure to O3 with CAPs [17].
Rodent models of multipollutant exposures have also been
utilized to examine biological responses. In an allergic
mouse model, both DE and O3 were needed to increase
lung resistance, which was not observed with individual
pollutant exposures [18]. Exposures of rats to resuspended
DE particles and O3 induced changes in some aortic
mRNA [19] suggesting changes induced by pollutant com-
ponents traversing the lung.
There is the possibility that exposure to one pollutant
may sensitize an individual in a manner that a biological
response from an exposure to a second pollutant may beenhanced. Sequential O3 and DE exposures in healthy
young adult participants in a controlled exposure setting
has demonstrated that an initial exposure to 300 μg/m3
DE for 1 hr followed 5 hr later by a 2 hr exposure to
0.2 ppm O3 induced more lung inflammation (e.g. neutro-
phils) than DE alone with no O3 exposure [20]. The same
research group, using a similar exposure regimen, showed
that a prior exposure to DE increased O3-induced lung in-
flammation relative to O3 exposure alone [21]. However,
these studies did not report on lung function changes.
Combinations of exposure to sulfuric acid aerosols and O3
have demonstrated slightly additive lung function changes
in asthmatic subjects [22] but not in healthy individuals
[23]. This study primarily examined whether combina-
tions of exposures to O3 and DE can induce additive or
synergistic effects related to lung function changes in
healthy, normal adults, whether exposure to DE alters
the response to a subsequent exposure to O3 approxi-
mately 20 hrs later, and whether GSTM1 genotype status
has an effect on the lung function responses.
Materials and Methods
Population characteristics
15 healthy, non-smoking volunteers (4 female, 11 male)
completed all four Day 1 exposure regimens (a-d; de-
scribed below) out of 25 subjects enrolled. Volunteers
ranged in age from 23 to 36 (mean 27), had no history
of asthma, chronic respiratory or acute illnesses within
4 weeks, and normal lung function (greater than 75% of
predicted values for FVC, FEV1, and FEV1/FVC ratio).
The volunteers refrained from taking non-steroidal
anti-inflammatory medications 48 hr prior to each ex-
posure. The use of vitamin C and E were not permitted
for 2 weeks prior to exposure. [See Additional file 1
(Subject Selection and Participation Criteria) for full
subject inclusion and exclusion criteria and subject par-
ticipation requirements as well as the study purpose].
Participants were informed of the procedures and likely
potential risks and each signed a statement of informed
consent. Subject participation was strictly voluntary and
they could withdraw at any time. The protocol and con-
sent form were approved by the University of North
Carolina School of Medicine Committee on the Protec-
tion of the Rights of Human Subjects and the US EPA
[ClinicalTrials.gov # NCT01874834]. Once consented,
volunteers were trained to correctly perform pulmonary
function tests, BMI calculated, and participants exer-
cised on a recumbent bicycle to determine a load that
would elicit minute ventilation of 25 L/min/m2 body
surface area (BSA) (~50 L/min for most subjects). BSA
and BMI (in kg/m2) was calculated by the spirometry
software from a subject’s height and weight. GSTM1
status was determined from isolated peripheral white
blood cell DNA (QIAamp DNA Mini Kit (Qiagen Inc.,
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standard venipuncture during the training day before
any exposures occurred. One subject did not consent to
genotyping and was not utilized in the analyses by geno-
type group. Subject characteristics are presented in
Table 1.
Study design
This was a randomized crossover single blind study with
4 arms (designated as a-d) separated by at least 13 days
between arms. Each arm consisted of 2 consecutive ex-
posure days and a follow-up visit (Figure 1). On Day 1
participants were exposed for 2 hr with intermittent ex-
ercise to arm a) filtered air (FA) n = 3 (where n is the ini-
tial exposure); arm b) DE (300 ug/m3 target) n = 4; arm
c) O3 (0.300 ppm target) n = 4; or arm d) DE +O3, n = 4.
On Day 2 (~22 hr post Day 1 exposure) all research sub-
jects were exposed to O3 (0.300 ppm target) for 2 hrs. A
follow-up visit occurred on Day 3. No two subjects re-
ceived the same sequence of arms (as there were 24
possible sequences). Prior to the first exposure (Day 1,
pre), lung function was measured on a 10.2-L dry seal
digital spirometer interfaced to a computer (Sensor-
Medics Model 1022; SensorMedics; Palm Springs, CA)
with subjects standing. Subjects then entered a stain-
less steel exposure chamber (approximately 1.83 m ×
1.83 m × 2.44 m, ~8.17 m3; ~650 ft3/min flow; air change
time ~ 27 sec), and were exposed to filtered air, DE, O3, or
DE +O3 for 2 h. During the exposure, subjects exercised
on a recumbent bicycle ergometer for 15 min intervalsTable 1 Subject characteristics of participants in the
study
Gender Race Age BMI GSTM1 status
f c 24 26.84 Pos
f bl 27 32.16 Pos
m c 37 24.19 Pos
m c 27 24.37 Null
m bl 36 28.47 Null
m c 27 27.08 Pos
m hisp 24 29.94 Pos
m hisp 24 27.15 Null
m c 23 25.22 Nos
m bl 23 29.37 Pos
f c 25 25.66 Null
f bl 29 38.06 Pos
m c 30 21.22 Pos
m c 28 28.94 Null
m c 25 25.72 nd
11 m/4f 9c/4bl/2hisp 27 ± 4 27.63 ± 3.95 9+/5-
nd = not determined.beginning after the first 15 min of exposure and resting
for 15 min after each exercise time for a total of 1 hr of ex-
ercise per exposure. Ventilation rate was measured ap-
proximately 6 min into each exercise session and work
load adjusted if needed to a target of 25 L/min/m2 BSA.
Heart rate, ECG, and SpO2 (using pulse oximetry) were
monitored continuously during the exposure. Immediately
following the exposure (Day 1, post), subjects underwent
pulmonary function testing. Lung function measurements
were obtained once an hour for the next 4 hrs. On Day 2,
the procedures described for Day 1 were repeated except
that participants entered a different chamber (~2.39 m ×
2.16 m × 3.20 m, ~ 16.52 m3; 450 ft3/min) for an O3 ex-
posure. The following morning (Day 3, follow-up), there
was a final round of pulmonary function testing. Subjects
who had a large Day 1 decrement in lung function were
not exposed on Day 2, but did return for follow-up lung
function testing.
Exposure conditions
All exposures were carried out at the EPA Human Studies
Facility in Chapel Hill, NC. The targeted exposure atmos-
phere was approximately 40 ± 10% RH and 22 ± 2°C. Out-
door air was passed through an air purification system
consisting bed of Purifil (potassium permangate on alu-
mina), a bed of Purikol (activated charcoal), dehumidified,
and passed over an unheated bed of Hopcalite and then
through a HEPA filter to ensure no detectable presence of
pollutant gases (O3, NO, NO2, SO2, CO, and hydrocar-
bons with the exception of methane) in the FA. The air
was then heated, humidified, and passed through a second
HEPA filter before O3 and DE were added. The concentra-
tions of the pollutant gases and PM were monitored con-
tinuously. The DE was generated from a Cummins diesel
engine/generator QSB7 series (model DSGAA) running at
50 percent load that was located outside the Facility, and
subsequently introduced into the exposure chamber after
dilutions with humidified FA to give a chamber concentra-
tion target of approximately 300 μg/m3. The DE particle
concentration was controlled by modulating the flow of
medical grade compressed air into a Vortec Transvector
Air Flow Amplifier (Model 901XSS; Cincinati OH) with
real time TEOM monitoring of PM mass concentration.
Diesel fuel used for the study was a commercially obtained
ultra low sulfur (<15 ppm) fuel. Particle mass, numbers,
and size characteristics were measured in real time by a
DataRAM™, a Tapered Element Oscillating Microbalance
(TEOM®), and a Condensation Particle Counter (CPC).
The CPC TSI 3022A model (detection size limit 7 nm)
was used for the first 11 subjects’ exposures, and a TSI
3775 model (detection size limit 4 nm) was used for the
last 4 subjects’ exposures for detection of particle number
concentration. A Scanning Mobility Particle Sizer (SMPS™)
(Shorewood MN) as also used to measure particulate
Arm Day 1 Day 2 Day 3 
A     Air O3 FU
B     DE O3 FU
C     O3 O3 FU
D     DE + O3 O3 FU
Figure 1 Design of Study. Subjects were exposed to target levels of either filtered air, 0.300 ppm O3, 300 ug/m
3 DE, or combined DE (300 ug/m3)
and O3 (0.300 ppm) on Day 1 for 2 hr. On Day 2 subjects were exposed to 0. 300 ppm O3 for 2 hr. During exposures on Days 1 and 2 subjects
performed four 30 min cycles of rest/exercise at ~ 50 L/min. Day 3 was a follow-up (F/U) day for measurements and no pollutant exposures occurred.
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data were used to determine particle size distribution
as a number median diameter in all size bins. The
number median diameter is the particle size (μm) bin
where the median of the total count number occurs.
Particle size distribution was determined at regular in-
tervals. A Versatile Air Pollution Sampler (VAPS)
(URG, Chapel Hill NC) configured with one quartz
and two teflon filters with flow controlled by a mass
flow controller sampled inlet air to the chamber. After
exposure and filter weight determination, filter sam-
ples were analyzed for chemical composition of parti-
cles. Elemental (EC) and Organic (OC) Carbon content
were determined using a thermo-optical method based
on sequential pyrolytic vaporization and detection by
transmittance using a carbon analyzer (Model 107A,
Sunset Laboratory Inc., Hillsborough, NC) [25]. A bac-
terial endotoxin characterization test on particles was
conducted by Cape Cod Inc. (East Falmouth, Massa-
chusetts) using a Limulus polyphemus gel clot method
to test for endotoxin contamination following their
standard operating procedures.
Ozone was generated by passing USP grade oxygen
through a silent arc O3 generator (Innovatee Gerate-
technmik GmbH, Rheinbach Germany) (Model CMG
10–5 for the DE chamber (Day 1) and Model 500 for the
O3 chamber on Day 2). For Day 1 exposures O3 entered
the filter air stream before DE. Concentrations were
controlled by a computer feedback to the O3 generator
with a 0-5 V signal allowing internal modulation control
of the O3 generator. Both DE and O3 were delivered into
the exposure chamber within 8 sec to minimize DE loss.
Increased production of O3 was needed when DE was
present as NO reacted with O3.
Statistics
The primary hypothesis of this study was to examine
whether combinations of exposures to O3 and DE in-
duce synergistic effects on lung function and whether
exposures to DE sensitize individuals for a larger re-
sponse to O3 than does the exposure by air. To evaluate
changes between pollutant and filtered air exposures we
used a full two-factor (arm b plus arm c (O3 plus DE),and arm d (O3 +DE)) mixed effects model with a subject-
specific random intercept to account for repeated measures.
To examine the first hypothesis with respect to synergism
of effects, changes in lung function were examined follow-
ing Day 1 exposures. To examine whether exposures to
DE sensitize individuals for a larger response to O3, lung
function was examined following O3 exposure on Day 2.
In both analyses changes in lung function were contrasted
to null hypothesis of no change relative to pre exposure
baseline and relative to air exposure as control. Prior to
the analysis, lung function endpoints FEV1 and FEV were
normalized and expressed as percent change from the
pre-exposure values (Post/Pre-1). All 15 subject subjects
completed four exposures on Day 1. Following O3 expos-
ure on day 1 some subjects responded with large drop in
lung function and were not asked to undergo a Day 2 O3
exposure. On day 2, 15 subjects completed O3 exposures
following air and DE (arms a and b, respectively), 14 of
these completed O3 exposure following O3 on Day 1 (arm c),
and 11 completed Day 2 O3 exposure following of the
combined O3 & DE exposure (arm d). We used all avail-
able data in the analysis and did not account for possibly
non-random missing values in subjects who responded
strongly to O3 or O3 & DE on day 1. Estimated mean
changes in lung function within each exposed group at
each time point are expressed as mean change ± standard
error, and a p-value where applicable. All statistical ana-
lyses were performed using R statistical software, with
nlme and gmodes packages to estimate the effect (version
3.0.1; R Developement Core Team; http://www.r-project.




The subjects were exposed to 290 μg/m3 DE and
0.298 ppm O3 exposure on average during individual
pollutant exposure days (Table 2). On co-exposure days,
the values were very similar; 291 μg/m3 and 0.296 ppm for
DE and O3 respectively. The values for other measured
parameters (Table 2; CO, and TH) were also similar for
the DE and DE +O3 exposures. When both O3 and DE
were present together, there was a decrease in NO and a
Table 2 Mean Day 1 pollutant physicochemical parameters during the four exposure scenarios
Parameter Air O3 DE DE + O3
PM (μg/m3)a 1.0 ± 1.5 1.0 ± 1.1 297. 1 ± 20.8 294.3 ± 20.1
PM # (x103/cc) <1 <1 731 ± 90b (11) 734 ± 50b (11)
977 ± 55c (4) 903 ± 306c (4)
Median PM size
Volume (μm) ----- ----- 0.200 ± 0.007 0.200 ± 0.007
Number (μm)d ----- ----- 0.064 ± 0.006 0.066 ± 0.003
O3 ppm 0.00 ± 0.00 0.30 ± 0.00 0.01 ± 0.00 0.30 ± 0.00
CO (ppm) 0.09 ± 0.10 0.09 ± 0.10 2.58 ± 0.25 2.51 ± 0.32
NO (ppm) 0.00 ± 0.01 0.01 ± 0.03 1.58 ± 0.26 0.03 ± 0.04
NO2 (ppm) 0.00 ± 0.00 0.00 ± 0.00 0.16 ± 0.05 1.72 ± 0.22
THC (ppm) 2.05 ± 0.10 1.98 ± 0.10 2.35 ± 0.14 2.24 ± 0.19
SO2 (ppm) <0.010 <0.010 0.013 <0.010
mean ± Std Dev except for Median PM size; n = 15, except for PM# where n is indicated.
aGravimetric weight; average of two teflon filters.
bCPC Model TSI 3022A.
cCPC Model TSI 3775.
dparticle size (μm) bin where the median of the particle counts occurred.
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were exposed to O3 alone, the concentration was main-
tained within 0.010 ppm of the targeted concentration.
The median DE number and volume particle size (64 nm
and 200 nm, respectively) did not change with O3 present
(number size 66 nm and volume size 200 nm, respect-
ively). There were 731 and 734 (x103) particles/cc for DE
and DE +O3 exposures, respectively when one CPC
model was used (n = 11); the numbers increased when the
second model was used (n = 4) due to a different detect-
able size limit. Particle EC and OC concentrations on sam-
ple filters were 39.2 ± 4.6 ug/cm2 and 14.2 ± 3.5 ug/cm2,
respectively, i.e., ~ 3:1 ratio. PM from both DE and DE +
O3 exposures had nondetectable levels of endotoxin.
Lung function after exposures to pollutants on Day 1
Fifteen subjects completed all four of the Day 1 pollution
exposure scenarios. In these subjects, decreases (relative
to their pre-exposures values) in FEV1 were not observed
immediately after exposure to either FA or whole DE
(Figure 2A). Measurement of lung function revealed
no decrement in DE or air exposed subjects for up to
4 hrs post-exposure. Exposure to O3 induced an aver-
age decrement of 9.9 ± 2.5% measured immediately
post-exposure (p < 0.05 vs air exposure). Exposure to
the combination of O3 and DE induced a decrement of
17.6 ± 4.6% and was statistically different from both air
and O3 alone exposure (p < 0.01). A greater than additive
effect of the DE and O3 exposure (arm d) on FEV1 was
examined by statistical comparison to the FEV1 changes
following O3 (arm c) added to the change following DE
exposure (arm b). The analysis had a p value of 0.057,
close to statistical significant. FEV1 values returned topre-exposure values by 4 hr post-exposure in the O3
and DE + O3 groups at similar rates.
Among the Day 1 exposures statistically significant
(p < 0.01) FVC decrements were observed in O3-exposed
subjects (8.7 ± 2.3%) and DE +O3 exposed subjects (11.8 ±
3.0%) immediately post-exposure compared to FA expo-
sures (Figure 2B). The FVC decrements immediately post
O3 compared to post DE +O3 exposure were not statisti-
cally different (p = 0.10), nor was greater than additive
effects observed when FVC changes in arm d were com-
pared to the sum of FVC changes post O3 and DE. Ex-
posure to either air or DE alone did not alter FVC from
pre-exposure values. FVC values returned to pre-exposure
levels by 4 hrs post-exposure for all exposure groups with
no difference in the recovery rate (data not shown).
Analysis stratified by GSTM1 genotype showed relatively
small and non-significant decrease in FEV1 in GSTM1null
individuals (n = 5) (0.8 ± 0.7%) immediately post DE expos-
ure compared to individuals with a GSTM1+ genotype
who did not have a decrease (FEV1 increased 1.3 ± 0.5%;
n = 9) (Figure 3). Immediately after the O3 exposure, the
group of GSTM1null genotype individuals had a smaller,
and statistically non-significant, decrease in FEV1, 3.70 ±
2.0% compared to a 13.7 ± 4.2% decrement in the GSTM1
+ group. Using linear regression, an individual’s BMI did
not significantly correlate with their observed O3-induced
or DE and O3-induced FEV1 or FVC change.
Lung function after exposure to O3 on Day 2
After Day 1 exposures, subjects returned to the facility
and most were exposed to about 0.300 ppm O3. For lung
function measured immediately post-exposure, subjects
in arm a (exposed to air on day 1) had a statistically
























Figure 3 Day 1 Changes in FEV1 immediately after a Day1
exposure in GSTM1- individuals. Mixed Effects Model testing was
used for statistical analysis.
Day 1 Exposures: FEV1 Decrement & Recovery




















p=0.057 vs (O3) plus (DE)




















































Figure 2 Changes in FEV1 (A) and FVC (B) after Day 1 pollutant
exposures. Subjects performed pre-exposure spirometry immediately
before a 2 hr exposure (filtered air, O3, DE, or DE + O3). Spirometry was
performed immediately post-exposure and every hour post-exposure
for 4 hr. FVC Data in (B) derived from the immediately post time point
only. Data in the figure are presented as the mean ± SEM of each
group at that time point. *p < 0.05 vs air exposed; **p < 0.05 vs O3
exposure alone; ‡ p = 0.057 vs the sum of the O3 plus DE exposure
FEV1 changes using Mixed Effects Model testing as described in the
materials and methods section.
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and FVC (7.8 ± 1.8%) immediately post-exposure when
compared to pre-exposure values (Figure 4A and 4B).
Exposure to O3 after the previous day exposure to DE
(arm b) induced statistically significant decrements of
14.7 ± 3.3% for FEV1 and 9.2 ± 1.9% for FVC (both p < 0.05).
The Day 2 O3-induced FEV1 and FVC decrements foreach subject after the Day 1 exposure to DE compared
to air showed that prior exposure to DE on Day 1 induced
a statistically significant greater FEV1 decrement on Day 2
(p < 0.05) (Figure 5).
Some subjects were not sequentially exposed to Day 2
O3 either due to their request or due to their large dec-
rement in FEV1 immediately after either O3 (n = 1) or
DE + O3 (n = 4) on Day 1 because a second sequential
O3 exposure within 24 hr is expected to typically induce
an even larger FEV1 decrement than the first day expos-
ure in most subjects. Consequently, for those five sub-
jects Day 2 procedures were follow-up measurements
and observations, similar to Day 3 measurements for
the other 10 subjects. Subjects in this study had a
greater O3-induced lung function decrements if they re-
ceived two consecutive days of O3 exposure (arm c);
consecutive O3 exposures induced a statistically signifi-
cant greater decrement in FEV1 (18.2 ± 4.5%) than the
decrement associated immediately after the first day
exposure, (i.e., 10.3 ± 3.3%,) (p < 0.05) (Figure 4A) or
compared to the Day 1 air exposure, then O3 on Day 2
(i.e., 10.9 ± 2.6%) . The FVC decrement (7.8 ± 1.8%) on
Day 2 following air (arm a) (Figure 4B) was similar to
the Day 1 FVC decrement (8.7%) after O3 (Figure 2B).
For subjects exposed to DE + O3 (arm d) the FEV1 dec-
rement immediately after exposure to O3 on Day 2 was
13.8 ± 2.2% , which was similar to the decrement in
these subjects the previous day immediately after ex-
posure (i.e., 17.6 ± 4.6%). The FVC decrement on Day 2
(Figure 4B) was similar to the Day 1 FVC decrement as
well (Figure 2B). Both FEV1 and FVC values returned
to pre-exposure values by 4 hr post exposure (data not
shown).
When FEV1 responses to the Day 2 O3 exposure were
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Figure 4 Changes in FEV1 (A) and FVC (B) immediately post
Day 2 O3 exposure (0. 300 ppm). *p < 0.05 vs air exposed values






















Figure 5 Individual changes (n = 15) in FEV1 immediately after
Day 2 O3 exposure for individuals exposed to either air or DE
on day 1. *p < 0.05 vs air exposure using Mixed Effects
Model testing.
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rement (3.8 ± 3.8%) than positive genotypes (14.9 ± 3.6%)
after the FA exposure day; however this difference was
not significant. This is a consistent effect with the ob-
served Day 1 responses to O3 exposure between the two
groups. No other Day 2 FEV1 differences were observed
between genotypes for the other 3 exposure regimens
from Day 1.
Discussion
This study examined alterations in lung function after
co-exposures of DE and O3, as well as sequential expo-
sures to DE and O3 separated by one day. For the former
exposure regimen, DE alone did not induce lung functionas measured by FEV1 and FVC decrements, but O3 did
induce decrements after 2 hr reaching statistical signifi-
cance for FEV1. Exposure of the subjects to the combin-
ation of the two pollutants (arm d) induced a greater FEV1
decrement than either pollutant alone. If the pollutant-
induced FEV1 changes are added together, i.e., the sum of
the changes in FEV1 post O3 and post DE exposures, and
compared to the combined exposure (arm d), the p value
of 0.057 is obtained and is close to statistical significance
(Figure 2A). A possible explanation for the synergistic ef-
fect induced by DE +O3 co-exposure may be that the lung
function change is related to the chemical composition in
the atmosphere containing O3 and DE being different
from DE or O3 alone. DE-derived particle size did not
change with the presence of O3, and chamber temperature
and humidity were kept similar between the two exposure
regimens, suggesting that particle deposition pattern in the
lung was not likely altered due to a size change. However,
the possibility that other PM physicochemically related
characteristics were altered, such as a change in charge or
hydrophobicity that could alter the deposition pattern can-
not be excluded. For all exposures regimens, lung function
returned to pre-exposure values by 4 hrs after the end of
the exposure, similar to the well characterized and transi-
ent nature of O3-induced lung function changes.
With respect to component changes in the gas phase
relating to the greater than additive effect of O3 and DE
on FEV1 decrement, the NO2 level increased while the
NO level decreased. However, NO2 alone generally does
not induce lung function changes even up to 4 ppm in
healthy individuals [26] though we cannot totally exclude
the possibility that it contributed to changes in lung func-
tion seen during co-exposure to DE and O3. O3 concen-
trations were kept at ~ 0.300 ppm with or without DE
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tered concentrations were derived from DE. If lung func-
tion responses to O3 exposure are mediated at least in
part via C-fiber activation [27] then chemical components
affecting C-fibers activity directly (but below a threshold
for discharge), or indirectly by, e.g., lowering the fiber
threshold for electrical discharge, might be expected to in-
duce the synergistic change in FEV1 seen upon concur-
rent O3 and DE exposure. Some carbonyls, (e.g., acrolein)
and carboxylic acids (e.g., acetic acid) have been impli-
cated in affecting pulmonary C-fiber activity [28-30].
There are several aldehydes identified in DE including
acrolein, and there is increased formation of carbonyls
and carboxylic acids observed upon O3 reacting with DE
particles surface components [31]. There is evidence for a
possible increased carbonyls and/or carboxylic acids for-
mation and induction of C-fiber sensitization in the DE
and O3 atmosphere, but other classes of compounds can-
not be eliminate either.
Subjects in this study receiving DE exposure the day
before the Day 2 O3 exposure had greater FEV1 decre-
ments than when they had a Day 1 clean air exposure
(Figure 5). It is uncertain whether only the DE gas phase
or particle phase, or both phases, are needed to induced
the augmented response to a subsequent O3 exposure.
Most previous studies examining sequential exposure ef-
fects of air pollutants on O3-induced lung effects changes
were typically performed within 6 hr of the initial expos-
ure [20,21,32]. A report demonstrated that prior exposure
for 2 hr to 0.6 ppm NO2 with intermittent exercise
(~40 L/min) did not significantly alter lung function in
the young, healthy subjects; however compared to air as
the initial exposure, the pre-exposure to NO2 induced a
1.8% greater FEV1 decrement upon a 2 hr exposure to
0.300 ppm O3 3 hr post NO2 exposure [32]. Another
study reported that a same day follow up to approxi-
mately 0.200 ppm O3 added to the lung inflammatory
response (i.e., increased neutrophilia and myeloperoxi-
dase) induced by an initial 300 ug/m3 DE exposure
compared to an initial air exposure; but lung function
was not examined in that study [21]. A possible mech-
anism involved with the augmented FEV1 change to O3
on Day 2 in this study may involve, at least in part, al-
tered production of prostaglandins E2 (PGE2) and F2α
(PGF2α) which have been associated with O3-induced
lung function decrements [33]. Both prostaglandins can
alter lung C-fiber activity directly inducing discharge
and/or altering the threshold for discharge to an agonist
[34] The possible altered AA metabolism in response to
sequential DE and O3 exposures (i.e., increased AA re-
lease, decreased re-uptake, and COX-2 protein for in-
creased conversion of AA to PGE2 and F2α), based upon
in vivo and in vitro findings [35-39], may explain, at
least in part, the observed greater FEV1 decrement. Itshould be noted that an adequate duration of time is
needed for COX-2 protein to be upregulated [40]. Add-
itionally the literature suggests that the DE particle
phase is involved in this possible biochemical mechanism
(i.e., increased COX-2), but does not necessarily negate
the importance of DE gas phase components.
Factors that affect an individual’s sensitivity to O3-
induced lung function decrements are not clearly un-
derstood. Increased BMI has been linked to a greater
O3-induced lung function decrement though predomin-
antly driven by females with BMI > 25 [11]. In our study
no statistically significant changes were observed in the
whole population, and with only four female study partici-
pants the analyses was likely underpowered. Certain geno-
types, including GST isozymes, have been examined as
possible biomarkers of sensitivity. Specifically for this study,
GSTM1 genotype status was examined as the null ge-
notype was not associated with a greater FEV1 decrease
upon exposure of young, normal, healthy adults to a rela-
tively low 0.06 ppm O3 concentration for 6.6 hr with exer-
cise (24), though lung neutrophilia was associated with
the allele deletion. In our study, the GSTM1- subjects had
an approximately 10% smaller decrement to 0.300 ppm
O3 exposure than GSTM1+ subjects in arm c Day 1 and
arm a Day 2, though the difference did not reach statistical
significance. However, no increased resistance to develop-
ment of an FEV1 decrease was observed in the GSTM1-
group upon the co-exposure to DE and O3, possibly due
to a similar sensitivity to DE components or DE compo-
nents that were influenced by O3.
The modulation of O3-induced lung function changes
by DE exposure raise the possibility that such interactions
may occur from exposures to ambient levels of these pol-
lutants. Additionally the components in DE that altered
the magnitude of the O3-induced FEV1 changes may be
also present in our environment and potentially derived
from natural or anthropomorphic sources and not ex-
clusively from DE. It is unclear at what ambient concen-
trations DE may affect responsiveness to O3 exposure,
and also the threshold of O3 level that induces lung
function decrements; recent literature suggest it may be
as low as the 0.06-0.08 ppm range [24,41]. Additionally
populations sensitive to the DE-induced lung function
effects have not been fully identified, and remains an
ongoing issue.Additional file
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